agilon health (NYSE:AGL) Downgraded to Market Perform Rating by William Blair

William Blair cut shares of agilon health (NYSE:AGL) from an outperform rating to a market perform rating in a report released on Friday, Marketbeat reports.

Several other research analysts have also recently weighed in on the stock. Citigroup reiterated a “sell” rating and set a $2.50 price target (down previously from $7.00) on shares of agilon health in a research note on Tuesday, October 29th. Benchmark reiterated a “buy” rating and set a $9.00 target price on shares of agilon health in a research report on Thursday, August 8th. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target for the company. in a research report on Wednesday, October 2nd. Evercore ISI lowered their price objective on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 8th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $8.00 price objective on shares of agilon health in a research note on Wednesday, August 7th. Three equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, agilon health presently has an average rating of “Hold” and a consensus target price of $7.81.

agilon health Stock Performance

Shares of agilon health stock traded down $0.95 during trading on Friday, hitting $1.84. 19,089,565 shares of the company’s stock traded hands, compared to its average volume of 4,945,005. agilon health has a 1 year low of $1.80 and a 1 year high of $13.76. The business has a 50-day simple moving average of $3.26 and a 200-day simple moving average of $4.97. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.36 and a quick ratio of 1.36. The stock has a market capitalization of $757.12 million, a P/E ratio of -2.52 and a beta of 0.60.

agilon health (NYSE:AGL) last released its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share for the quarter, meeting the consensus estimate of ($0.07). The firm had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The company’s revenue was up 38.7% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.04) EPS. As a group, analysts forecast that agilon health will post -0.32 EPS for the current year.

Insider Buying and Selling

In other agilon health news, CEO Steven Sell purchased 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was purchased at an average cost of $3.36 per share, with a total value of $67,200.00. Following the purchase, the chief executive officer now owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 3.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On agilon health

Several hedge funds have recently modified their holdings of the business. J.Safra Asset Management Corp grew its stake in agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after buying an additional 3,625 shares during the last quarter. City State Bank acquired a new stake in agilon health in the third quarter worth about $52,000. CWM LLC grew its stake in shares of agilon health by 406.5% during the second quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after acquiring an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC acquired a new position in shares of agilon health during the second quarter valued at about $60,000. Finally, Bleakley Financial Group LLC purchased a new position in shares of agilon health in the 1st quarter valued at approximately $65,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.